FundedIQ
Biotechnology

Serán Bioscience: Funding, Investors & Team (Sep 2026)

Serán is a contract development and manufacturing organization providing a comprehensive suite of development, analytical and clinical manufacturing services to pharmaceutical and biotechnology companies.

www.seranbio.com LinkedIn Bend, United States 251-500 employees
Biotechnology Clinical Trials Manufacturing Pharmaceutical B2B
Total raised
$200M
Rounds
1
Latest
Undisclosed round
Sep 2024

Serán Bioscience has raised $200M across 1 funding round on record, the most recent an undisclosed round of $200M announced in Sep 2024.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Serán Bioscience Company Profile and Key Stats

Total funding raised
$200M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$200M in Sep 2024
Employees
251-500
reported band
Headquarters
Bend, United States

Latest funding round on record: Sep 2024.

Serán Bioscience Funding Rounds

Date
Round
Amount
Undisclosed round
$200M

Serán Bioscience Founders and Leadership Team

Name
Role
Contact
Dan Smithey
Founder
Locked

Contact details for the Serán Bioscience team: 1 of 1 has an email address on file.

Start 14-day free trial →

Serán Bioscience Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M

Serán Bioscience's latest round of $200M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Serán Bioscience in Biotechnology and Bend

Companies Similar to Serán Bioscience

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Serán Bioscience Funding FAQs

What does Serán Bioscience do?

Serán is a contract development and manufacturing organization providing a comprehensive suite of development, analytical and clinical manufacturing services to pharmaceutical and biotechnology companies.

How much funding has Serán Bioscience raised?

Serán Bioscience has raised $200M across 1 round on record. The most recent is an undisclosed round of $200M announced in Sep 2024.

When did Serán Bioscience last raise funding?

Serán Bioscience's most recent funding round on record is an undisclosed round of $200M, announced in Sep 2024.

Who founded Serán Bioscience?

FundedIQ lists Dan Smithey (Founder) at Serán Bioscience.

Where is Serán Bioscience headquartered?

Serán Bioscience is based in Bend, Oregon, United States.

How many employees does Serán Bioscience have?

Serán Bioscience is in the 251-500 employee band.

How does Serán Bioscience's funding compare to other Biotechnology startups?

Serán Bioscience's latest round of $200M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Serán Bioscience Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Serán Bioscience is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.